LifeStance Health Group, Inc. (NASDAQ:LFST) Q1 2026 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Mark, and I will be your conference operator for today. [Operator Instructions] Thank you.
Lifestance Health Group Inc. (LFST)
Market is closed
Sector: Services-Health Services
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 3,606,755 | $38,628,346 | +90% | 0.01% |
| 2. | Integral Health Asset Management Bhagwan Jay Rao | 3,000,000 | $32,130,000 | -31% | 1.27% |
| 3. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,068,445 | $22,153,046 | +14% | 0.07% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,627,266 | $17,428,019 | +584% | 0.01% |
| 5. | First Eagle Investment Management Jean-Marie Eveillard | 1,562,966 | $16,739,366 | -3% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.30 | 46,511 | $199,997.30 | 46,511 | 2025-08-08 | Filing | |
| $4.54 | 18,660 | $84,716.40 | 3,436,571 | 2025-08-11 | Filing | |
| $4.35 | 1,340 | $5,829.00 | 3,417,991 | 2025-08-11 | Filing | |
| $4.31 | 1,800 | $7,758.00 | 3,416,571 | 2025-08-08 | Filing | |
| $4.36 | 45,870 | $199,993.20 | 3,414,771 | 2025-08-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.68 | 7,500 | $95,100.00 | 97,093 | 2026-08-14 | Filing | |
| $12.23 | 20,441 | $249,993.43 | 104,593 | 2026-08-13 | Filing | |
| $11.51 | 500,000 | $5,755,000.00 | 2,970,810 | 2026-08-11 | Filing | |
| $10.85 | 44,394 | $481,674.90 | 247,446 | 2026-08-10 | Filing | |
| $10.62 | 13,643,207 | $144,890,858.34 | 98,101,407 | 2026-08-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 111,744,614 | $1,196,784,816 | 23.93% | |
| 2. | 58,252,466 | $623,883,915 | 0.03% | |
| 3. | 36,348,507 | $389,292,501 | 0.01% | |
| 4. | 23,310,115 | $249,651,332 | 41% | |
| 5. | 13,960,892 | $149,521,153 | 0.01% |
News See All
10 Stocks Boasting High Double-Digit Gains
Ten stocks climbed by huge double-digit gains on Thursday, leaving Wall Street’s three major indices in the dust, thanks to a flurry of strong corporate earnings and upbeat outlooks for their businesses...
Canaccord Lifts PT on LifeStance Health Group (LFST) to $10 From $9, Here's Why
LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the best hot stocks under $20 to buy. On February 26, Canaccord lifted the price target on LifeStance Health Group, Inc.
10 Hot Stocks Under $20 to Buy
On February 24, Luke Barrs, Goldman Sachs Asset Management chief business and client officer for fundamental equities, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends and ...
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2025 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST) Q4 2025 Earnings Call Transcript February 25, 2026LifeStance Health Group, Inc. misses on earnings expectations.
Analysts Turn More Bullish on LifeStance Health Group (LFST) After Dual Price Target Hikes
TheFly reported on January 8 that KeyBanc analyst Steve Dechert increased the price target for LFST from $6.50 to $8.50, keeping an Overweight rating on the stock.
15 High Growth Mid-Cap Stocks to Buy
The US stock market is shifting as President Trump reinforces his “America First” agenda through subsidies and incentives aimed at boosting domestic manufacturing.
2026 Medical Utilization Forecasts Support BTIG's Bullish View on LifeStance (LFST)
On December 12, BTIG analyst David Larsen reiterated his bullish stance on LifeStance Health Group (NASDAQ:LFST). The analyst rated the stock as Buy and raised the price target from $9 to $10 a share.
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
LifeStance (LFST) Soars 30% on Q3 Earnings Blowout
LifeStance recovered by 29.94 percent on Thursday to close at $6.25 apiece as investors welcomed its impressive earnings performance in the third quarter of the year, solidifying expectations for a strong...
Hedge Fund Resource Center